boundlessbio.com (BOLD) - Utang marang Ekuitas

Lambang korporat lan logo Boundless Bio (BOLD)

Boundless Bio, Inc. (BOLD) is developing cancer therapies focusing on extrachromosomal DNA, where current R&D expenditures will transition into high profits following drug registration. Unique patents and significant investments in bioinformatics serve as a moat for the business. The price action for the company shown on this chart demonstrates a total debt-to-equity ratio of 0.00. Projects are implemented within US jurisdiction, eliminating the impact of trade wars.

BOLD: Total Utang marang Modal boundlessbio.com 29.03.2024 - 28.10.2026

Rincian analitis perusahaan Boundless Bio, Inc.

- rega lan prakiraan konsensus rega:
Rega saham Boundless Bio|BOLD - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Boundless Bio|BOLD - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Boundless Bio|BOLD - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku boundlessbio.com|BOLD - Aset Agregat Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Boundless Bio, Inc.|BOLD - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Boundless Bio, Inc.|BOLD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Boundless Bio
Ringkesan analisis perusahaan:BOLD Boundless Bio
Sampel barang boundlessbio.com

Boundless Bio, Inc. (BOLD) invests in the development of targeted drugs to combat aggressive oncogenesis caused by ecDNA, which requires significant capital expenditures. An analysis of the financial leverage ratio (total debt-to-equity) allows for an assessment of the proportion of borrowed funds relative to equity, revealing the business's degree of dependence on creditors and determining the final cost of financing the company's innovation strategy.

Pesaing utama

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS - Total Utang marang Modal|RARE: Utang marang Ekuitas|Utang marang Ekuitas BEAM|Utang marang Modal Sarepta Corp|TWST (Twist Bioscience) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal TXG|Utang marang Ekuitas Intellia Therapeutics, Inc. NTLA|Rasio Utang marang Ekuitas Stoke Therapeutics Inc (STOK)|BLFS - Total Utang marang Modal|Wave Pharma - Rasio Utang marang Ekuitas|MAZE - Utang marang Ekuitas|SION - Utang marang Ekuitas|Total Utang marang Modal PRME|TSHA (Taysha Gene Therapies Inc) - Utang marang Modal|QURE: Utang marang Ekuitas|Koefisien Total Utang marang Modal MGTX|RGNX (REGENXBIO Inc.) - Utang marang Ekuitas|Koefisien Total Utang marang Modal solidbio.com SLDB|Rasio Total Utang marang Ekuitas Ocugen|Rasio Kabeh Utang marang Dana Pribadi Pacific Biosciences of California, Inc. PACB|BNTC - Total Utang marang Modal|DSGN - Utang marang Ekuitas|Rocket Pharmaceuticals - Total Utang marang Modal|FDMT (4dmoleculartherapeutics.com) - Koefisien Total Utang marang Modal|Utang marang Ekuitas LXEO (Lexeo Therapeutics Inc.)|Utang marang Modal Korro Bio, Inc (KRRO)|Editas (EDIT) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Silence Therapeutics Corp (SLN)|Total Utang marang Modal PRQR|Codexis Inc - Koefisien Total Utang marang Modal|Sangamo Therapeutics, Inc. (SGMO) - Utang marang Ekuitas|NAUT - Rasio Utang marang Ekuitas|MGX (Metagenomi, Inc) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Precision BioSciences Inc.|GBIO: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Exicure Corp|Total Utang marang Modal Imunon, Inc. (IMNN)|Utang marang Ekuitas PHIO (phiopharma.com)|MBIO: Utang marang Ekuitas|TransCode Therapeutics Inc. - Utang marang Modal|BNGO - Utang marang Ekuitas|APDN - Utang marang Ekuitas|Total Utang marang Modal bluebird bio|ImmunoPrecise Antibodies Ltd. (IPA) - Rasio Utang marang Ekuitas|Total Utang marang Modal Omega (OMGA)|Rasio Utang marang Ekuitas OMIC|Utang marang Ekuitas Regulus Therapeutics RGLS|Rasio Utang marang Ekuitas syros.com (SYRS)|Total Utang marang Modal TBIO (Telesis Bio)|Total Utang marang Modal TRACON Pharmaceuticals Inc. TCON|UBX - Total Utang marang Modal